Program Overview
Antihyperglycemic agents how to tailor treatment to individual patients is one of six programs offered in the 2023 Diabetes Simplified Series. The Diabetes Simplified series aims to provide practical approaches to diabetes care that practitioners can immediately implement in their practices, based on the Diabetes Canada Clinical Practice Guidelines.
This eLearning reviews the guideline recommendations for antihyperglycemic agents with a focus on tailoring antihyperglycemic treatment in people with type 2 diabetes.
This program has been certified by the College of Family Practice of Canada for up to 2 MainPro+ credits.
Learning Objectives
- Determine when and how to initiate basal insulin in people with type 2 diabetes.
- Discuss the role of SGLT2 inhibitors in people with diabetes and heart failure with preserved ejection fraction (HFpEF).
- Examine the current KDIGO 2022 guidelines for the management of diabetes and chronic kidney disease (CKD).
- Discuss the evidence supporting the combination of a SGLT2 inhibitor and a GLP-1 receptor agonist.
Faculty
Gihane Zarifa
MD, CCFP, FCFP, MSc, BSc
Gihane (Gen) Zarifa completed her Bachelor of Sciences in Microbiology and her Masters of Sciences at the University of Toronto. She received her MD degree from the University of Toronto in 2000 and completed her training in Family Medicine in 2002. She is an assistant Professor with the University of Toronto and a Fellow with the College of Family Physicians of Canada. She received her Clinical Teacher Certificate in 2014.
